Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108715574B reveals a green Sm-Cu catalyzed route for 4,4'-biphenol. Achieve high purity and cost reduction in fine chemical manufacturing with recyclable ionic liquids.
Patent CN110590819A introduces a chitosan-copper catalyzed method for organoboron compounds. Offers cost reduction in pharmaceutical intermediates manufacturing with water-based green chemistry.
Patent CN105037381A enables green synthesis using ionic liquids. Reduces waste and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101857579B details a green one-pot synthesis using acidic ionic liquids. Achieve high purity pharmaceutical intermediates with reduced waste and scalable processes.
Patent CN106977470B enables green synthesis of 2-iminothiazoline derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN120136770B reveals a green one-pot photocatalytic synthesis for anti-liver cancer indole intermediates, offering metal-free cost reduction and scalable supply chain solutions.
Patent CN111909038A introduces a safe, low-pressure Schiff base catalyzed route for phenylenediamine, offering significant cost and safety advantages over traditional nitration.
Patent CN117964512B reveals a low-toxicity synthesis route for N,N-dimethyl-3-methoxypropionamide using Lewis acid catalysts, offering significant supply chain and cost advantages for industrial buyers.
Novel acid-catalyzed method reduces aldehyde usage and eliminates metal catalysts for cost-effective manufacturing.
Patent CN107721969B reveals a safe, high-yield route for chiral TADDOLs using isopropyl magnesium bromide, offering significant cost reduction and supply chain reliability.
Patent CN105884570B enables mild arylation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111138299A details a solvent-free method for triarylmethanes. Offers high purity, reduced waste, and scalable production for pharma intermediates.
Patent CN110372633B details a transition-metal-free reduction method using NaBEt3H, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN114522738B enables efficient 1,3-propanediol synthesis via Cu-catalysis. Delivers supply chain stability and cost reduction in polymer intermediate manufacturing.
Patent CN101056853B reveals a novel Pd-catalyzed regioselective hydrogenation route for isoindole derivatives, offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Patent CN110028407A reveals a rare earth catalyzed method for spiro[cyclopropane-1,2'-indene]-1',3'-dione synthesis offering high stereoselectivity and supply chain advantages.
Novel Ni(II)-SNC catalyst enables high-yield sulfide oxidation under mild conditions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Advanced synthesis of arylamine nitrogen mustard derivatives via patent CN106631857A. Offers reduced toxicity and enhanced therapeutic index for pharmaceutical manufacturing.
Novel asymmetric synthesis patent CN119930414B offers high yield and purity. Reliable supplier for pharma intermediates with scalable processes.
Novel room-temperature asymmetric catalysis for chiral secondary aryl alcohols. Reduces cost by eliminating noble metals. High yield and ee for pharma intermediates.